Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled Trial

Inclusion Criteria: * Aged ≥ 19 years who are willing and able to complete all procedures * Hepatic steatosis by imaging (ultrasound, computed tomography, magnetic resonance imaging, and controlled attenuation parameter (≥260 dB/m)) Exclusion Criteria: * Body mass index (BMI) \<23 * Other causes of chronic liver disease (HBV, HCV), autoimmune diseases or chronic cholestatic liver disease * Medications which cause liver disease or secondary hepatic steatosis (Tamoxifen, systemic corticosteroids, methotrexate, tetracycline, estrogens, valproic acid, and statin (registration is possible if statin is delivered in a consistent dosage within 12 weeks) * Significant alcohol intake (\>210g/week for men, \>140g/week for women) * Severe medical comorbidities (ischemic heart disease, 3rd degree atrioventricular block, chronic obstructive pulmonary disease, severe hypertension (blood pressure \> 200/120 mmHg) * Psychiatric illnesses which limit ability to exercise safely * Diagnosed with diabetes on medication or insulin * Participation in a weight-loss program within 12 weeks * MRI contraindications